buparvaquone has been researched along with naphthoquinones in 100 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (8.00) | 18.7374 |
1990's | 32 (32.00) | 18.2507 |
2000's | 24 (24.00) | 29.6817 |
2010's | 31 (31.00) | 24.3611 |
2020's | 5 (5.00) | 2.80 |
Authors | Studies |
---|---|
Ahmed, JS; Dobbelaere, D; Rintelen, M; Schein, E; Williams, RO | 1 |
Dolan, TT; Gisemba, F; Injairu, R; Maina, JN; Mbadi, G; Mbwiria, SK; Mulela, GH; Othieno, DA | 1 |
Kariuki, DP; Lampard, D; Lesan, AC; Linyonyi, A; Mining, SK; Ndungu, SG; Ngumi, PN; Williamson, SM; Young, AS | 1 |
Lane, VM; Zaugg, JL | 2 |
McHardy, N | 1 |
Coquerelle, TM; Dobbelaere, DA; Eichhorn, M; Kelke, C; Roditi, IJ; Williams, RO | 1 |
Kocan, AA; Mitema, ES; Mukolwe, SW; Sangiah, S; Sherban, D | 1 |
Kariuki, DP; Morzaria, SP; Mutugi, JJ; Tameno, JM; Young, AS | 1 |
Hashemi-Fesharki, R | 1 |
Motzel, SL; Wagner, JE | 1 |
de Vos, AJ; McHardy, N; Standfast, NF; Stewart, NP | 1 |
Ahmed, JS; Rintelen, M; Schein, E | 1 |
Mishra, AK; Sharma, NN | 1 |
Bhushan, C; Dhar, S; Gautam, OP; Malhotra, DV | 3 |
el Refaii, AH; McHardy, N; Michael, SA; Rae, DG | 1 |
Bansal, GC; Sharma, NN | 1 |
Bogan, JA; Kinabo, LD | 1 |
Leitch, BL; Linyonyi, A; Maritim, AC; Mbogo, SK; Mutugi, JJ; Young, AS | 1 |
Hudson, AT; McHardy, N; Randall, AW; Wekesa, LS | 1 |
Mishra, AK; Sharma, NN; Viswanathan, CB | 1 |
Gill, JS; Kwatra, MS; Sharma, KK; Singh, J | 1 |
Armson, A; Grubb, WB; Mendis, AH; Reynoldson, JA; Thompson, RC | 1 |
Raghav, PR; Singh, DK; Thakur, M; Varshney, BC | 1 |
Hagiwara, K; Ishihara, C; Iwai, H; Kurosawa, T; Tajima, M; Takahashi, K; Tsuji, M | 1 |
Kariuki, DP; Mbogo, SK; McHardy, N; Ngumi, PN | 1 |
Davis, WC; Dobbelaere, DA; Jungi, TW; Sager, H | 1 |
Davis, W; Dobbelaere, D; Eichhorn, M; Galley, Y; Glaser, I; Hagens, G | 1 |
Ahmed, JS; Shayan, P | 1 |
Croft, SL; Furtado Campos, JH; Miles, MA; Vexenat, JA | 1 |
Brown, CG; Ilhan, T; Kirvar, E; Shiels, B; Williamson, S | 1 |
Bell-Sakyi, LJ; Brown, CG; Kirvar, BE; Sparagano, O; Thomas, M; Wilkie, GM; Williamson, SM | 1 |
Bröker, BM; Fich, C; Fleischer, B; Klauenberg, U | 1 |
Brown, CG; Kirvar, E; Sparagano, O; Thomas, EM; Wilkie, GM | 1 |
Beniwal, RK; Nichani, AK; Sharma, RD | 1 |
el-Metenawy, TM | 1 |
Naziroğlu, M; Saki, CE; Sevgili, M | 1 |
Kiara, HK; McHardy, N; Muraguri, GR | 1 |
Lewis, BD; López-Rebollar, LM; Penzhorn, BL; Swan, GE | 1 |
Croft, SL; Luque-Ortega, JR; Rivas, L; Rivero-Lezcano, OM | 1 |
Jacobs, C; Kayser, O; Müller, RH | 1 |
Jacobs, C; Müller, RH | 1 |
Angelisová, P; Baumgartner, M; Horejsí, V; Langsley, G; Mooney, N; Setterblad, N; Werling, D | 1 |
Chen, ZJ; Dobbelaere, DA; Fernandez, PC; Heussler, VT; Küenzi, P; McKellar, S; Orth, K; Rottenberg, S; Schwab, R; Shiels, B; Wallach, D | 1 |
Anson, CE; Croft, SL; Davies, W; Gokhale, NH; Kendrick, HD; Padhye, SB; Powell, AK | 1 |
Dobbelaere, DA; Küenzi, P; Schneider, P | 1 |
Dessauge, F; Garcia, A; Guergnon, J; Langsley, G | 1 |
Dwivedi, SK; Gupta, AK; Kumar, S; Pal, Y | 1 |
Croft, SL; Garnier, T; Järvinen, T; Koskinen, A; Mäntylä, A; Nevalainen, T; Rautio, J; Vepsälainen, J | 1 |
Aktas, M; Dabak, DO; Dabak, M | 1 |
Croft, SL; Garnier, T; Järvinen, T; Juvonen, R; Kendrick, H; Mäntylä, A; Nevalainen, T; Rautio, J; Vepsälainen, J | 1 |
Boniphace, S; Gwamaka, M; Maselle, RM; Matovelo, JA; Mbassa, GK; Mtambo, MM | 1 |
Järvinen, T; Keski-Rahkonen, P; Mäntylä, A; Nevalainen, T; Rautio, J; Vepsälainen, J | 1 |
Bang, K; Dunne, J; Fox, A; McHardy, N; Muraguri, GR; Ndungu, SG; Ngumi, PN; Wanjohi, JM; Wesonga, D | 1 |
Magwisha, HB; Mbwambo, HA; Mfinanga, JM | 1 |
Croft, SL; Mansor, SM; Nair, NK; Navaratnam, V; Ramanathan, S; Sattar, MA; Venkatesh, G | 1 |
Brown, MB; Croft, SL; Garnier, T; Järvinen, T; Lawrence, MJ; Mäntylä, A | 1 |
Al-Gaabary, MH; Osman, SA | 1 |
Brown, M; Croft, S; Garnier, T; Järvinen, T; Lawrence, J; Mäntylä, A | 1 |
Croft, SL; Majid, MI; Mansor, SM; Nair, NK; Navaratnam, V; Ramanathan, S; Venkatesh, G | 1 |
Paşa, S; Saruhan, B | 1 |
Glass, EJ; Hulme, MJ; Jensen, K; Kaliszewska, A; Makins, GD; Paxton, E | 1 |
Croft, SL; Majid, MI; Mansor, SM; Nair, NK; Navaratnam, V; Venkatesh, G | 1 |
BenAbderazzak, S; Boumiza, A; Chaabani, MF; Darghouth, MA; Mhadhbi, M; Naouach, A | 1 |
Ahmed, JS; Beyer, D; Gerber, S; Haller, D; Kullmann, B; Mackiewicz, M; Schneider, I; Seitzer, U | 1 |
Ding, F; Guo, J; Li, LY; Li, Z; Lian, J; Song, WH; Zhang, JH; Zhang, JY; Zhu, L | 1 |
Colombo, FA; Pereira-Chioccola, VL; Reimão, JQ; Tempone, AG | 1 |
Namazi, F; Oryan, A; Razavi, M; Shahriari, R; Sharifiyazdi, H | 1 |
Aguiar, MG; Carneiro, G; Fernandes, AP; Ferreira, LA | 1 |
Greene, MI; Hattori, M; Hayashida, K; Kajino, K; Morrison, I; Sugimoto, C; Wallace, M | 1 |
Lawrence, JA; Prozesky, L; Steyl, JC; Stoltsz, WH | 1 |
Baird, M; Durrani, Z; Kinnaird, JH; Pillai, SS; Shiels, BR; Weir, W | 1 |
Ait-Si-Ali, S; Chluba, J; DeBarry, JD; Fritsch, L; Garrido, C; Lopez, T; Lu, KP; Marsolier, J; Medjkane, S; Mhadhbi, M; Perichon, M; Villoutreix, BO; Weitzman, JB; Zhou, XZ | 1 |
Awan, MM; Jamal, Q; Khan, NH; Shah, A; Sutherland, C; Wahid, S | 1 |
Aguado-Martinez, A; Arranz-Solís, D; Balmer, V; Hemphill, A; Hostettler, I; Manser, V; Müller, J; Ortega-Mora, L; Ritler, D; Winzer, P | 1 |
Ajroud, K; BenAbderrazak, S; Chaouch, M; Darghouth, MA; Mhadhbi, M | 1 |
Aguado-Martínez, A; Haynes, RK; Hemphill, A; Manser, V; Müller, J; Wong, HN | 1 |
Hillerton, JE; McDougall, S; Pegram, D | 1 |
Bartolomé, A; Checa, R; Gálvez, R; González-Fraga, JL; Marino, V; Miró, G; Montoya, A; Ortega, N | 1 |
Aguado-Martínez, A; Barrett, LK; Choi, R; Ferre, I; Hemphill, A; Hulverson, MA; Maly, DJ; McCloskey, MC; Moreno-Gonzalo, J; Müller, J; Ojo, KK; Ortega-Mora, LM; Van Voorhis, W | 1 |
Abd El-Aty, AM; Chang, BJ; Cho, SH; Jeong, JH; Kim, JS; Kim, SK; Park, JA; Shim, JH; Shin, HC; Shin, SC; Wang, Y; Zhang, D | 1 |
Choudhury, S; Gupta, KK; Shanker, D; Singh, SK; Srivastava, M; Sudan, V | 1 |
Bolás-Fernández, F; Dea-Ayuela, MA; Lalatsa, A; Mauger, M; Serrano, DR; Smith, L | 1 |
Hemphill, A; Manser, V; Müller, J | 1 |
D'Ascoli, L; Dick, L; Hemphill, A; Hizem, A; Lundström-Stadelmann, B; Ritler, D; Rufener, R; Wells, TNC | 1 |
Abdo Abubaker, H; Amin Alnour, S; Chatanga, E; Katakura, K; Mosssad, E; Nakao, R; Salim, B | 1 |
Awino, E; Nene, V; Nyagwange, J; Pelle, R; Svitek, N; Tijhaar, E | 1 |
Marsolier, J; Medjkane, S; Perichon, M; Weitzman, JB | 1 |
Guan, G; Hassan, MA; Liu, J; Luo, J; Mukhtar, MU; Rashid, M; Rashid, MI; Wang, X; Yin, H; Zhao, S | 1 |
Bou-Chacra, N; Cotrim, PC; de Araújo, GLB; Fotaki, N; Löbenberg, R; Monteiro, LM | 1 |
Bishop, RP; Dolan, RB; Dolan, TT; Odongo, DO; Sayer, PD; Skilton, RA | 1 |
Chaudhari, PR; Devarajan, PV; Maithania, HV; Mohanty, BS; Samad, A | 1 |
Gedye, K; Lawrence, KE; Pomroy, WE | 1 |
Chatanga, E; Jannot, G; Mossaad, E; Nakao, R; Salim, B; Weitzman, JB | 1 |
Adewusi, O; Adriana de Jesus, J; Auxiliadora Dea-Ayuela, M; Bolas-Fernandez, F; Dalastra Laurenti, M; Felipe Domingues Passero, L; Lalatsa, A; Serrano, DR; Statts, L | 1 |
Lehto, VP; Mondal, S; Näkki, S; Närvänen, A; Nissinen, T; Rantanen, J; Riikonen, J; Thapa, R | 1 |
Barbosa, EJ; Bou-Chacra, NA; de Araujo Eliodoro, RH; de Araujo, GLB; de Freitas, VLT; Fotaki, N; Kanashiro, E; Löbenberg, R; Monteiro, LM; Rocha, M; Sato, PK | 1 |
Dan, XG; Guan, GQ; Li, X; Liu, JL; Zhao, HX | 1 |
1 review(s) available for buparvaquone and naphthoquinones
Article | Year |
---|---|
Drug delivery systems for the topical treatment of cutaneous leishmaniasis.
Topics: Administration, Cutaneous; Aminoquinolines; Amphotericin B; Animals; Antiprotozoal Agents; Drug Delivery Systems; Humans; Imiquimod; Leishmaniasis, Cutaneous; Naphthoquinones; Paromomycin; Phosphorylcholine; Skin Absorption | 2012 |
5 trial(s) available for buparvaquone and naphthoquinones
Article | Year |
---|---|
A clinical trial of buparvaquone in the treatment of East Coast fever.
Topics: Anaplasmosis; Animals; Antiprotozoal Agents; Cattle; Injections, Intramuscular; Kenya; Naphthoquinones; Theileria parva; Theileriasis | 1992 |
Stage-specific activity in vitro on the Theileria infection process of serum from calves treated prophylactically with buparvaquone.
Topics: Animals; Antiprotozoal Agents; Biological Assay; Cattle; Cell Line; Naphthoquinones; Theileria annulata; Theileria parva; Theileriasis; Time Factors | 1998 |
In-vivo therapeutic efficacy trial with artemisinin derivative, buparvaquone and imidocarb dipropionate against Babesia equi infection in donkeys.
Topics: Animals; Antiprotozoal Agents; Artemisinins; Babesiosis; Blood Cell Count; Drug Therapy, Combination; Equidae; Imidocarb; India; Naphthoquinones; Sesquiterpenes; Splenectomy | 2003 |
Clinical efficacy and plasma concentrations of two formulations of buparvaquone in cattle infected with East Coast fever (Theileria parva infection).
Topics: Animals; Antiprotozoal Agents; Area Under Curve; Cattle; Cattle Diseases; Male; Naphthoquinones; Theileriasis | 2006 |
Clinical, haematological and therapeutic studies on tropical theileriosis in water buffaloes (Bubalus bubalis) in Egypt.
Topics: Animals; Antiprotozoal Agents; Buffaloes; Cattle; Cattle Diseases; Egypt; Naphthoquinones; Theileriasis | 2007 |
94 other study(ies) available for buparvaquone and naphthoquinones
Article | Year |
---|---|
Effect of buparvaquone on the expression of interleukin 2 receptors in Theileria annulata-infected cells.
Topics: Animals; Cattle; Cells, Cultured; Gene Expression Regulation; Humans; Interleukin-2; Lymphocyte Activation; Lymphocytes; Naphthoquinones; Receptors, Interleukin-2; Recombinant Proteins; RNA, Messenger; Theileria annulata | 1992 |
Further evaluation of the use of buparvaquone in the infection and treatment method of immunizing cattle against Theileria parva derived from African buffalo (Syncerus caffer).
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Buffaloes; Cattle; Evaluation Studies as Topic; Immunization; Naphthoquinones; Oxytetracycline; Theileria parva; Theileriasis | 1992 |
Efficacy of buparvaquone as a therapeutic and clearing agent of Babesia equi of European origin in horses.
Topics: Acute Disease; Animals; Antibodies, Protozoan; Antiprotozoal Agents; Babesia; Babesiosis; Carrier State; Complement Fixation Tests; Female; Fluorescent Antibody Technique; Horse Diseases; Horses; Injections, Intravenous; Male; Naphthoquinones; Splenectomy | 1992 |
Integrated strategy to control East Coast fever.
Topics: Animals; Antiprotozoal Agents; Cattle; Immunization; Naphthoquinones; Theileriasis; Tick Control | 1991 |
Lymphocytes infected with Theileria parva require both cell-cell contact and growth factor to proliferate.
Topics: Animals; Apicomplexa; Cattle; Cell Adhesion; Cell Communication; Cell Division; Growth Substances; In Vitro Techniques; Interleukin-2; Lymphocytes; Lymphokines; Naphthoquinones; Theileriasis | 1991 |
Activity of buparvaquone against Theileria cervi in white-tailed deer.
Topics: Animals; Antiprotozoal Agents; Apicomplexa; Cells, Cultured; Chloroquine; Deer; Erythrocytes; Hypoxanthine; Hypoxanthines; Imidocarb; Naphthoquinones; Theileriasis | 1991 |
Epidemiological observations on theileriosis following field immunisation using infection and treatment.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Apicomplexa; Arachnid Vectors; Carrier State; Cattle; Disease Reservoirs; Female; Fluorescent Antibody Technique; Immunization; Male; Naphthoquinones; Nymph; Oxytetracycline; Pregnancy; Pregnancy Complications, Infectious; Theileriasis; Ticks | 1991 |
Chemotherapeutic value of parvaquone and buparvaquone against Theileria annulata infection of cattle.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Cattle; Iran; Naphthoquinones; Theileriasis | 1991 |
Treatment of experimentally induced cytauxzoonosis in cats with parvaquone and buparvaquone.
Topics: Animals; Antiprotozoal Agents; Apicomplexa; Cat Diseases; Cats; Female; Male; Naphthoquinones; Protozoan Infections; Protozoan Infections, Animal | 1990 |
Elimination of Theileria buffeli infections from cattle by concurrent treatment with buparvaquone and primaquine phosphate.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Apicomplexa; Cattle; Drug Therapy, Combination; Naphthoquinones; Primaquine; Random Allocation; Theileriasis | 1990 |
Buparvaquone but not cyclosporin A prevents Theileria annulata-infected bovine lymphoblastoid cells from stimulating uninfected lymphocytes.
Topics: Animals; Antiprotozoal Agents; Apicomplexa; Cattle; Cells, Cultured; Cyclosporins; Host-Parasite Interactions; Lymphocyte Activation; Lymphocytes; Naphthoquinones; Theileriasis | 1990 |
Treatment of bovine tropical theileriosis with buparvaquone.
Topics: Animals; Antiprotozoal Agents; Cattle; Injections, Intramuscular; Male; Naphthoquinones; Theileriasis | 1990 |
Chemoimmunoprophylaxis against bovine tropical theileriosis in young calves: a comparison between buparvaquone and long-acting oxytetracycline.
Topics: Animals; Cattle; Naphthoquinones; Oxytetracycline; Random Allocation; Theileriasis; Ticks | 1990 |
Effect of treatment of chronic theileriosis with buparvaquone on milk yields.
Topics: Animals; Antiprotozoal Agents; Body Temperature; Cattle; Female; Lactation; Naphthoquinones; Pregnancy; Random Allocation; Theileriasis | 1989 |
Evaluations of buparvaquone as a treatment for equine babesiosis (Babesia equi).
Topics: Animals; Antiprotozoal Agents; Babesiosis; Carrier State; Horse Diseases; Horses; Male; Naphthoquinones; Splenectomy; Time Factors | 1989 |
Prophylactic efficacy of buparvaquone in experimentally induced Theileria annulata infection in calves.
Topics: Animals; Antiprotozoal Agents; Cattle; Male; Naphthoquinones; Random Allocation; Theileriasis | 1989 |
Parvaquone and buparvaquone: HPLC analysis and comparative pharmacokinetics in cattle.
Topics: Animals; Antiprotozoal Agents; Cattle; Chromatography, High Pressure Liquid; Naphthoquinones | 1988 |
Immunization of cattle using varying infective doses of Theileria parva lawrencei sporozoites derived from an African buffalo (Syncerus caffer) and treatment with buparvaquone.
Topics: Animals; Antiprotozoal Agents; Apicomplexa; Buffaloes; Carrier State; Cattle; Dose-Response Relationship, Immunologic; Immunization; Naphthoquinones; Oxytetracycline; Theileriasis; Thelazioidea | 1988 |
Treatment of experimentally induced Theileria annulata infection in cross-bred calves with buparvaquone.
Topics: Acute Disease; Animals; Antiprotozoal Agents; Body Temperature; Cattle; Erythrocytes; Hematocrit; Hemoglobins; Injections, Intramuscular; Lymph Nodes; Naphthoquinones; Random Allocation; Theileriasis; Ticks | 1988 |
Chemoimmunoprophylaxis with buparvaquone against theileriosis in calves.
Topics: Animals; Antiprotozoal Agents; Cattle; Naphthoquinones; Theileriasis | 1987 |
Antitheilerial activity of BW720C (buparvaquone): a comparison with parvaquone.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Apicomplexa; Cattle; Chemical Phenomena; Chemistry; Kenya; Naphthoquinones; Species Specificity; Theileriasis | 1985 |
Efficacy of Butalex in field cases of bovine theileriosis--short communication.
Topics: Animals; Antiprotozoal Agents; Cattle; Female; Male; Naphthoquinones; Theileriasis; Treatment Outcome | 1993 |
Treatment of theileriosis in crossbred cattle in the Punjab.
Topics: Age Factors; Animals; Antiprotozoal Agents; Cattle; India; Naphthoquinones; Oxytetracycline; Protozoan Vaccines; Theileria; Theileriasis; Vaccination | 1993 |
The efficacy of two electron transport inhibitors (720C80 and 993C76) on murine strongyloidiasis: a comparison with albendazole.
Topics: Albendazole; Animals; Antiprotozoal Agents; Female; Naphthoquinones; Rats; Rats, Sprague-Dawley; Strongyloidiasis | 1993 |
Chemotherapeutic trials with four drugs in crossbred calves experimentally infected with Theileria annulata.
Topics: Animals; Antiprotozoal Agents; Cattle; Male; Naphthoquinones; Oxytetracycline; Quinazolines; Quinazolinones; Theileria annulata; Theileriasis | 1993 |
The Bo-RBC-SCID mouse model for evaluating the efficacy of anti-theilerial drugs.
Topics: Aminoquinolines; Animals; Antiprotozoal Agents; Cattle; Diminazene; Drug Evaluation, Preclinical; Erythrocyte Transfusion; Female; Mice; Mice, SCID; Models, Biological; Naphthoquinones; Theileria | 1993 |
A mild Theileria parva parasite with potential for immunisation against East Coast fever.
Topics: Animals; Antiprotozoal Agents; Cattle; Immunization; Naphthoquinones; Protozoan Vaccines; Theileria parva; Theileriasis; Time Factors | 1996 |
Macrophage-parasite relationship in theileriosis. Reversible phenotypic and functional dedifferentiation of macrophages infected with Theileria annulata.
Topics: Animals; Antigens, Surface; Antiprotozoal Agents; Cattle; Cell Differentiation; Cell Line, Transformed; Down-Regulation; Female; Flow Cytometry; Host-Parasite Interactions; Lipopolysaccharides; Macrophages; Naphthoquinones; Phenotype; Sensitivity and Specificity; Theileria annulata; Theileriasis | 1997 |
Jun NH2-terminal kinase is constitutively activated in T cells transformed by the intracellular parasite Theileria parva.
Topics: 8-Bromo Cyclic Adenosine Monophosphate; Animals; Antiprotozoal Agents; Calcium-Calmodulin-Dependent Protein Kinases; Cell Line; Enzyme Activation; Enzyme Inhibitors; Humans; Immunosuppressive Agents; Indoles; JNK Mitogen-Activated Protein Kinases; Kinetics; Lymph Nodes; Lymphocyte Activation; Maleimides; Mitogen-Activated Protein Kinase 9; Mitogen-Activated Protein Kinases; Naphthoquinones; Polyenes; Protein Kinase C; Protein Kinases; Receptor-CD3 Complex, Antigen, T-Cell; Sirolimus; T-Lymphocytes; Tacrolimus; Theileria parva | 1997 |
Theileria-mediated constitutive expression of the casein kinase II-alpha subunit in bovine lymphoblastoid cells.
Topics: Animals; Antiprotozoal Agents; Casein Kinase II; Cattle; Cell Division; Cell Line; Concanavalin A; Dichlororibofuranosylbenzimidazole; DNA; Gene Expression Regulation; Lymphocytes; Mitogens; Naphthoquinones; Nucleic Acid Synthesis Inhibitors; Protein Serine-Threonine Kinases; RNA, Messenger; Theileria annulata; Theileria parva; Ticks | 1997 |
Failure of buparvaquone (Butalex) in the treatment of canine visceral leishmaniosis.
Topics: Animals; Antiprotozoal Agents; Dog Diseases; Dogs; Female; Injections, Intramuscular; Leishmaniasis, Visceral; Male; Naphthoquinones | 1998 |
Theileria annulata: carrier state and immunity.
Topics: Animals; Antibodies, Protozoan; Antibody Formation; Antigens, Protozoan; Antigens, Surface; Antiprotozoal Agents; Carrier State; Cattle; Cell Line; Enzyme-Linked Immunosorbent Assay; Fluorescent Antibody Technique, Indirect; Life Cycle Stages; Male; Naphthoquinones; Polymerase Chain Reaction; RNA, Protozoan; RNA, Ribosomal; Sensitivity and Specificity; Theileria annulata; Theileriasis; Ticks | 1998 |
Chemoprophylaxis of Theileria annulata and Theileria parva infections of calves with buparvaquone.
Topics: Animals; Antibodies, Protozoan; Antiprotozoal Agents; Cattle; Fluorescent Antibody Technique, Indirect; Naphthoquinones; Parasitemia; Theileria annulata; Theileria parva; Theileriasis | 1998 |
Modulation of enzymatic activity of Src-family kinases in bovine T cells transformed by Theileria parva.
Topics: Animals; Antiprotozoal Agents; Cattle; Cell Line, Transformed; Herpesvirus 2, Saimiriine; Humans; Jurkat Cells; Naphthoquinones; Phosphorylation; Precipitin Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; src-Family Kinases; T-Lymphocytes; Theileria parva; Tyrosine | 1998 |
Susceptibility to tropical theileriosis of calves born to dams immunized with Theileria annulata (Hisar) cell culture vaccine.
Topics: Animals; Animals, Newborn; Antibodies, Protozoan; Antigens, Protozoan; Antiprotozoal Agents; Arachnid Vectors; Body Temperature; Cattle; Disease Susceptibility; Female; Fluorescent Antibody Technique, Indirect; Hematocrit; Hemoglobins; Immunity, Maternally-Acquired; India; Naphthoquinones; Protozoan Vaccines; Theileria annulata; Theileriasis; Ticks; Vaccination | 1998 |
Therapeutic effects of some antihaematozoal drugs against Haemoproteus columbae in domestic pigeons.
Topics: Animals; Animals, Domestic; Antiprotozoal Agents; Bird Diseases; Coccidiosis; Columbidae; Diminazene; Haemosporida; Naphthoquinones; Quinolinium Compounds | 1999 |
The effect of buparvaquone treatment on the levels of some antioxidant vitamins, lipid peroxidation and glutathione peroxidase in cattle with theileriosis.
Topics: Animals; Antiprotozoal Agents; beta Carotene; Cattle; Cattle Diseases; Erythrocytes; Glutathione; Glutathione Peroxidase; Lipid Peroxidation; Naphthoquinones; Reference Values; Theileriasis; Vitamin A; Vitamin E; Vitamins | 1999 |
Treatment of East Coast fever: a comparison of parvaquone and buparvaquone.
Topics: Administration, Topical; Animals; Antimalarials; Biopsy; Cattle; Female; Fever; Injections, Intramuscular; Insecticides; Kenya; Male; Naphthoquinones; Nitriles; Parasitemia; Pyrethrins; Random Allocation; Theileriasis; Tick Infestations | 1999 |
Screening of five drugs for efficacy against Babesia felis in experimentally infected cats.
Topics: Animals; Anti-Infective Agents; Antiprotozoal Agents; Babesiosis; Cat Diseases; Cats; Drug Combinations; Enrofloxacin; Fluoroquinolones; Hematocrit; Naphthoquinones; Parasitemia; Primaquine; Quinolones; Rifampin; Sulfadiazine; Trimethoprim | 2000 |
In vivo monitoring of intracellular ATP levels in Leishmania donovani promastigotes as a rapid method to screen drugs targeting bioenergetic metabolism.
Topics: Adenosine Triphosphate; Animals; Antiprotozoal Agents; Cell Division; Cell Line; Dose-Response Relationship, Drug; Energy Metabolism; Firefly Luciferin; Kinetics; Leishmania donovani; Luciferases; Luminescent Measurements; Membrane Potentials; Mitochondria; Naphthoquinones; Parasitic Sensitivity Tests; Transfection | 2001 |
Production and characterisation of mucoadhesive nanosuspensions for the formulation of bupravaquone.
Topics: Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Chitin; Chitosan; Cryptosporidium parvum; Drug Delivery Systems; Drug Stability; Gels; Naphthoquinones; Particle Size; Suspensions | 2001 |
Buparvaquone mucoadhesive nanosuspension: preparation, optimisation and long-term stability.
Topics: Adhesives; Antiprotozoal Agents; Drug Stability; Hydrogels; Microscopy, Electron; Nanotechnology; Naphthoquinones; Particle Size; Technology, Pharmaceutical | 2002 |
Constitutive exclusion of Csk from Hck-positive membrane microdomains permits Src kinase-dependent proliferation of Theileria-transformed B lymphocytes.
Topics: Animals; Antiprotozoal Agents; B-Lymphocytes; Cattle; Cell Division; Cell Transformation, Neoplastic; CSK Tyrosine-Protein Kinase; Enzyme Activation; Enzyme Inhibitors; Lymphocyte Activation; Membrane Microdomains; Membrane Proteins; Naphthoquinones; Phenotype; Phosphatidylinositol 3-Kinases; Phosphoproteins; Protein-Tyrosine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-hck; Pyrimidines; Signal Transduction; src-Family Kinases; Theileria parva; Transcription Factor AP-1 | 2003 |
Hijacking of host cell IKK signalosomes by the transforming parasite Theileria.
Topics: Active Transport, Cell Nucleus; Animals; Antiprotozoal Agents; Apoptosis; Cattle; Cell Cycle; Cell Division; Cell Line, Transformed; Cell Nucleus; Down-Regulation; I-kappa B Kinase; I-kappa B Proteins; Leukocytes; Microscopy, Confocal; Naphthoquinones; NF-kappa B; Phosphorylation; Protein Serine-Threonine Kinases; Signal Transduction; Theileria | 2002 |
Transition metal complexes of buparvaquone as potent new antimalarial agents. 1. Synthesis, X-ray crystal-structures, electrochemistry and antimalarial activity against Plasmodium falciparum.
Topics: Animals; Antimalarials; Crystallography, X-Ray; Electrochemistry; Metals; Models, Molecular; Naphthoquinones; Oxidation-Reduction; Plasmodium falciparum; Spectrophotometry, Infrared | 2003 |
Theileria parva-transformed T cells show enhanced resistance to Fas/Fas ligand-induced apoptosis.
Topics: Animals; Antiprotozoal Agents; Apoptosis; Carrier Proteins; CASP8 and FADD-Like Apoptosis Regulating Protein; Caspases; Cattle; Cell Line, Transformed; Enzyme Activation; Fas Ligand Protein; fas Receptor; Homeostasis; Host-Parasite Interactions; Immunity, Innate; Inhibitor of Apoptosis Proteins; Intracellular Signaling Peptides and Proteins; Ligands; Membrane Glycoproteins; Naphthoquinones; Protein Biosynthesis; Proteins; T-Lymphocyte Subsets; Theileria parva; Up-Regulation; X-Linked Inhibitor of Apoptosis Protein | 2003 |
Apoptosis of Theileria-infected lymphocytes induced upon parasite death involves activation of caspases 9 and 3.
Topics: Amino Acid Chloromethyl Ketones; Animals; Antiprotozoal Agents; Apoptosis; Caspase 3; Caspase 9; Caspase Inhibitors; Caspases; Cattle; Cell Death; Cysteine Proteinase Inhibitors; Enzyme Activation; Naphthoquinones; Poly(ADP-ribose) Polymerases; T-Lymphocytes; Theileria parva; Theileriasis | 2003 |
Synthesis, in vitro evaluation, and antileishmanial activity of water-soluble prodrugs of buparvaquone.
Topics: Administration, Oral; Administration, Topical; Alkaline Phosphatase; Animals; Antiprotozoal Agents; Cricetinae; Female; Humans; Hydrolysis; In Vitro Techniques; Leishmania; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Macrophages, Peritoneal; Mice; Naphthoquinones; Organophosphates; Permeability; Prodrugs; Skin; Solubility; Water | 2004 |
Cerebral theileriosis in a Holstein calf.
Topics: Animals; Anti-Bacterial Agents; Antiprotozoal Agents; Brain Diseases; Cattle; Cattle Diseases; Erythrocytes; Injections, Intramuscular; Male; Naphthoquinones; Oxytetracycline; Polymerase Chain Reaction; Theileria; Theileriasis; Treatment Outcome | 2004 |
Synthesis and antileishmanial activity of novel buparvaquone oxime derivatives.
Topics: Animals; Antiprotozoal Agents; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Magnetic Resonance Spectroscopy; Microsomes, Liver; Molecular Structure; Naphthoquinones; Oximes; Rats; Rats, Wistar | 2004 |
The effect of dexamethasone and promethazine in combination with buparvaquone in the management of East Coast fever.
Topics: Animals; Antiprotozoal Agents; Cattle; Cattle Diseases; Dexamethasone; Drug Therapy, Combination; Glucocorticoids; Histamine H1 Antagonists; Male; Naphthoquinones; Promethazine; Pulmonary Edema; Random Allocation; Theileria; Theileriasis; Treatment Outcome | 2004 |
Design, synthesis and in vitro evaluation of novel water-soluble prodrugs of buparvaquone.
Topics: Alkaline Phosphatase; Antiprotozoal Agents; Buffers; Drug Design; Hydrolysis; Indicators and Reagents; Lipids; Magnetic Resonance Spectroscopy; Naphthoquinones; Prodrugs; Solubility | 2004 |
Evaluation of buparvaquone (BUTA-Kel KELA, Belgium) as a treatment of East Coast fever in cattle, in the peri-urban of Dar Es Salaam city, Tanzania.
Topics: Animals; Antiprotozoal Agents; Cattle; Cattle Diseases; Female; Male; Naphthoquinones; Tanzania; Theileria parva; Theileriasis; Treatment Outcome | 2006 |
Development and validation of RP-HPLC-UV method for simultaneous determination of buparvaquone, atenolol, propranolol, quinidine and verapamil: a tool for the standardization of rat in situ intestinal permeability studies.
Topics: Animals; Antiprotozoal Agents; Atenolol; Buffers; Chromatography, High Pressure Liquid; Drug Stability; Hydrogen-Ion Concentration; Intestinal Mucosa; Male; Molecular Structure; Naphthoquinones; Perfusion; Permeability; Propranolol; Quinidine; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet; Verapamil | 2007 |
Topical buparvaquone formulations for the treatment of cutaneous leishmaniasis.
Topics: Administration, Cutaneous; Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Ethanol; Female; Humans; In Vitro Techniques; Leishmaniasis, Cutaneous; Melanins; Mice; Mice, Inbred BALB C; Myristates; Naphthoquinones; Organophosphates; Polyethylene Glycols; Prodrugs; Propylene Glycol; Skin; Skin Absorption | 2007 |
In vivo studies on the antileishmanial activity of buparvaquone and its prodrugs.
Topics: Animals; Antiprotozoal Agents; Chemistry, Pharmaceutical; Female; Leishmania donovani; Leishmania major; Leishmaniasis, Cutaneous; Leishmaniasis, Visceral; Liver; Mice; Mice, Inbred BALB C; Naphthoquinones; Prodrugs; Skin | 2007 |
Optimization and validation of RP-HPLC-UV method with solid-phase extraction for determination of buparvaquone in human and rabbit plasma: application to pharmacokinetic study.
Topics: Animals; Antiprotozoal Agents; Chromatography, High Pressure Liquid; Humans; Molecular Structure; Naphthoquinones; Rabbits; Reproducibility of Results; Solid Phase Extraction; Spectrophotometry, Ultraviolet | 2008 |
[Therapeutic efficacy of buparvaquone (buparvon) in cattle with theileriosis].
Topics: Animals; Antiprotozoal Agents; Cattle; Erythrocytes; Injections, Intramuscular; Naphthoquinones; Theileriasis; Treatment Outcome | 2008 |
The protozoan parasite Theileria annulata alters the differentiation state of the infected macrophage and suppresses musculoaponeurotic fibrosarcoma oncogene (MAF) transcription factors.
Topics: Animals; Antiprotozoal Agents; Cattle; Cattle Diseases; Cell Dedifferentiation; Cell Differentiation; Host-Parasite Interactions; Macrophages; Maf Transcription Factors; Naphthoquinones; Phenotype; Theileria annulata; Theileriasis | 2009 |
In vitro and in vivo evaluation of self-microemulsifying drug delivery system of buparvaquone.
Topics: Animals; Chemistry, Pharmaceutical; Drug Delivery Systems; Drug Evaluation, Preclinical; Emulsifying Agents; Male; Naphthoquinones; Rabbits | 2010 |
In vivo evidence for the resistance of Theileria annulata to buparvaquone.
Topics: Animals; Antiprotozoal Agents; Cattle; Dairying; Disease Outbreaks; Drug Resistance; Hematocrit; Naphthoquinones; Parasitemia; Schizonts; Theileria annulata; Theileriasis; Treatment Failure; Tunisia | 2010 |
Cytoplasmic sequestration of p53 promotes survival in leukocytes transformed by Theileria.
Topics: Animals; Antiprotozoal Agents; bcl-2-Associated X Protein; Cattle; Cell Nucleus; Cell Survival; Concanavalin A; DNA, Complementary; Gene Amplification; Kinetics; Leukocytes; Naphthoquinones; Theileria annulata; Theileriasis; Transcription, Genetic; Tumor Suppressor Protein p53 | 2010 |
Evaluation and structure-activity relationship study of acute toxicity of naphthoquinones to Photobacterium phosphoreum, Photobacterium T3B.
Topics: Antiprotozoal Agents; Atovaquone; Microbial Sensitivity Tests; Naphthoquinones; Photobacterium; Structure-Activity Relationship; Toxicity Tests, Acute | 2010 |
Effectiveness of liposomal buparvaquone in an experimental hamster model of Leishmania (L.) infantum chagasi.
Topics: Animals; Antiprotozoal Agents; Cell Line; Cells, Cultured; Cricetinae; Disease Models, Animal; Humans; Inhibitory Concentration 50; Leishmania infantum; Leishmaniasis, Visceral; Liposomes; Macaca mulatta; Macrophages, Peritoneal; Male; Mesocricetus; Mice; Mice, Inbred BALB C; Naphthoquinones; Phosphatidylserines | 2012 |
Point mutations in the Theileria annulata cytochrome b gene is associated with buparvaquone treatment failure.
Topics: Animals; Antiprotozoal Agents; Cattle; Cytochromes b; Dairying; Drug Resistance; Female; Gene Expression Regulation; Naphthoquinones; Point Mutation; Theileria annulata; Theileriasis | 2012 |
MDM2 regulates a novel form of incomplete neoplastic transformation of Theileria parva infected lymphocytes.
Topics: Amino Acid Sequence; Animals; Apoptosis; bcl-2-Associated X Protein; Cattle; Cell Line; Cell Transformation, Neoplastic; Cisplatin; DNA Damage; Enzyme Activation; Lymphocyte Activation; Molecular Sequence Data; Naphthoquinones; NF-kappa B; Protein Isoforms; Proto-Oncogene Proteins c-mdm2; Signal Transduction; T-Lymphocytes; Theileria parva; Tumor Suppressor Protein p53 | 2013 |
Theileriosis (Cytauxzoonosis) in Roan antelope (Hippotragus equinus): field exposure to infection and identification of potential vectors.
Topics: Animals; Animals, Wild; Antelopes; Antiprotozoal Agents; DNA, Protozoan; Male; Naphthoquinones; Polymerase Chain Reaction; Rhipicephalus; Salivary Glands; South Africa; Theileria; Theileriasis; Tick Infestations | 2012 |
A Bovine Lymphosarcoma Cell Line Infected with Theileria annulata Exhibits an Irreversible Reconfiguration of Host Cell Gene Expression.
Topics: Animals; Cattle; Cell Differentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Gene Expression Regulation; Host-Parasite Interactions; Leukocytes; Lymphoma, Non-Hodgkin; Naphthoquinones; Theileria annulata; Transcription, Genetic | 2013 |
Theileria parasites secrete a prolyl isomerase to maintain host leukocyte transformation.
Topics: Animals; Cattle; Cell Line; Cell Transformation, Neoplastic; Drug Resistance; Host-Parasite Interactions; Humans; Leukocytes; Naphthoquinones; NIMA-Interacting Peptidylprolyl Isomerase; Parasites; Peptidylprolyl Isomerase; Protein Stability; Proto-Oncogene Proteins c-jun; Signal Transduction; SKP Cullin F-Box Protein Ligases; Theileria; Transcription Factor AP-1; Ubiquitination; Xenograft Model Antitumor Assays; Zebrafish | 2015 |
In-vitro sensitivity of Pakistani Leishmania tropica field isolate against buparvaquone in comparison to standard anti-leishmanial drugs.
Topics: Amphotericin B; Antimony Sodium Gluconate; Antiprotozoal Agents; Cell Line, Tumor; Child; Humans; Inhibitory Concentration 50; Leishmania tropica; Leishmaniasis, Cutaneous; Macrophages; Male; Meglumine; Meglumine Antimoniate; Naphthoquinones; Organometallic Compounds; Pakistan; Parasitic Sensitivity Tests | 2015 |
Buparvaquone is active against Neospora caninum in vitro and in experimentally infected mice.
Topics: Animals; Antiprotozoal Agents; Cells, Cultured; Coccidiosis; Female; Fibroblasts; Humans; Mice; Mice, Inbred BALB C; Naphthoquinones; Neospora | 2015 |
Sequence Polymorphism of Cytochrome b Gene in Theileria annulata Tunisian Isolates and Its Association with Buparvaquone Treatment Failure.
Topics: Animals; Antiprotozoal Agents; Cattle; Cytochromes b; Drug Resistance; Naphthoquinones; Point Mutation; Polymorphism, Single Nucleotide; Protozoan Proteins; Theileria annulata; Theileriasis; Treatment Failure | 2015 |
Repurposing of antiparasitic drugs: the hydroxy-naphthoquinone buparvaquone inhibits vertical transmission in the pregnant neosporosis mouse model.
Topics: Animals; Antiparasitic Agents; Coccidiosis; Female; Infectious Disease Transmission, Vertical; Male; Mice, Inbred BALB C; Naphthoquinones; Neospora; Pregnancy | 2016 |
Concentrations of buparvaquone in milk and tissue of dairy cows.
Topics: Animals; Antiprotozoal Agents; Cattle; Female; Injections, Intramuscular; Liver; Milk; Muscle, Skeletal; Naphthoquinones; Theileriasis | 2016 |
Efficacy, safety and tolerance of imidocarb dipropionate versus atovaquone or buparvaquone plus azithromycin used to treat sick dogs naturally infected with the Babesia microti-like piroplasm.
Topics: Animals; Antiprotozoal Agents; Atovaquone; Azithromycin; Babesia microti; Babesiosis; Dog Diseases; Dogs; Drug Therapy, Combination; Europe; Female; Imidocarb; Male; Naphthoquinones; Parasitemia; Polymerase Chain Reaction | 2017 |
Development of a murine vertical transmission model for Toxoplasma gondii oocyst infection and studies on the efficacy of bumped kinase inhibitor (BKI)-1294 and the naphthoquinone buparvaquone against congenital toxoplasmosis.
Topics: Animals; Antiprotozoal Agents; Disease Models, Animal; Female; Infectious Disease Transmission, Vertical; Male; Mice; Naphthalenes; Naphthoquinones; Piperidines; Pyrazoles; Toxoplasmosis, Animal; Toxoplasmosis, Congenital; Treatment Outcome | 2017 |
Residual detection of buparvaquone, nystatin, and etomidate in animal-derived food products in a single chromatographic run using liquid chromatography-tandem mass spectrometry.
Topics: Animals; Chromatography, High Pressure Liquid; Etomidate; Naphthoquinones; Nystatin; Swine; Tandem Mass Spectrometry | 2017 |
Variation in cardiac markers and electrocardiographic alterations in young calves naturally infected with bovine tropical theileriosis.
Topics: Animals; Antiprotozoal Agents; Biomarkers; Cattle; Creatine Kinase, MB Form; Electrocardiography; Heart; Naphthoquinones; Theileriasis; Troponin I | 2018 |
Orally Bioavailable and Effective Buparvaquone Lipid-Based Nanomedicines for Visceral Leishmaniasis.
Topics: Administration, Oral; Animals; Antiprotozoal Agents; Biological Availability; Cell Line; Disease Models, Animal; Drug Carriers; Drug Compounding; Drug Liberation; Drug Stability; Emulsions; Excipients; Feasibility Studies; Humans; Leishmania infantum; Leishmaniasis, Visceral; Lipids; Male; Mice; Mice, Inbred BALB C; Nanoparticles; Naphthoquinones; Solubility; Treatment Outcome | 2018 |
In vitro treatment of Besnoitia besnoiti with the naphto-quinone buparvaquone results in marked inhibition of tachyzoite proliferation, mitochondrial alterations and rapid adaptation of tachyzoites to increased drug concentrations.
Topics: Animals; Antiprotozoal Agents; Cell Line; Chlorocebus aethiops; Drug Resistance; Fibroblasts; Inhibitory Concentration 50; Microscopy, Electron, Transmission; Mitochondria; Naphthoquinones; Sarcocystidae; Vero Cells | 2019 |
Repurposing of an old drug: In vitro and in vivo efficacies of buparvaquone against Echinococcus multilocularis.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Drug Evaluation, Preclinical; Drug Repositioning; Echinococcosis; Echinococcus multilocularis; Electron Transport Complex III; Glucose-6-Phosphate Isomerase; Inhibitory Concentration 50; Life Cycle Stages; Mice; Microscopy, Electron, Transmission; Naphthoquinones; Parasite Load; Phenyl Ethers; Quinolones | 2018 |
Evidence of multiple point mutations in Theileria annulata cytochrome b gene incriminated in buparvaquone treatment failure.
Topics: Animals; Antiprotozoal Agents; Cattle; Cytochromes b; Drug Resistance; Naphthoquinones; Point Mutation; Sudan; Theileria annulata; Theileriasis; Treatment Failure | 2019 |
Leveraging the Medicines for Malaria Venture malaria and pathogen boxes to discover chemical inhibitors of East Coast fever.
Topics: Animals; Antimalarials; Antiprotozoal Agents; Cattle; Cell Line; Cell Proliferation; Dasatinib; Drug Repositioning; High-Throughput Screening Assays; Inhibitory Concentration 50; Leukocytes, Mononuclear; Naphthoquinones; Small Molecule Libraries; Theileria parva; Theileriasis | 2019 |
Secreted parasite Pin1 isomerase stabilizes host PKM2 to reprogram host cell metabolism.
Topics: Animals; Antiprotozoal Agents; Biological Transport; Carrier Proteins; Cattle; Cell Line, Transformed; Cell Transformation, Neoplastic; Enzyme Inhibitors; Gene Expression Regulation; Glucose; Host-Pathogen Interactions; Hypoxia-Inducible Factor 1, alpha Subunit; Lymphocytes; Membrane Proteins; Metabolic Networks and Pathways; Naphthoquinones; NIMA-Interacting Peptidylprolyl Isomerase; Protozoan Proteins; RNA, Small Interfering; Signal Transduction; Theileria; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2019 |
Establishment and Expression of Cytokines in a
Topics: Animals; Antigens; B-Lymphocytes; Cattle; Cytokines; Flow Cytometry; Gene Expression Regulation; Lipopolysaccharides; Macrophages; Naphthoquinones; Single-Cell Analysis; Theileria annulata; Theileriasis | 2019 |
Co-delivery of buparvaquone and polymyxin B in a nanostructured lipid carrier for leishmaniasis treatment.
Topics: Anti-Bacterial Agents; Biopolymers; Chitosan; Dextrans; Drug Combinations; Drug Delivery Systems; Leishmania infantum; Leishmaniasis; Lipids; Nanostructures; Naphthoquinones; Particle Size; Polymyxin B; Thermogravimetry | 2019 |
THEILERIOSIS IN MOUNTAIN BONGO REPATRIATED TO KENYA: A CLINICAL AND MOLECULAR INVESTIGATION.
Topics: Animals; Antelopes; Antiprotozoal Agents; Conservation of Natural Resources; Disease Outbreaks; Female; Kenya; Male; Naphthoquinones; Oxytetracycline; Theileria; Theileriasis | 2019 |
Shape mediated splenotropic delivery of buparvaquone loaded solid lipid nanoparticles.
Topics: Administration, Intravenous; Animals; Chemical Precipitation; Drug Delivery Systems; Female; Lipids; Mice; Microscopy, Electron, Scanning; Nanoparticles; Naphthoquinones; Particle Size; Spleen | 2020 |
A longitudinal study of the effect of Theileria orientalis Ikeda type infection on three New Zealand dairy farms naturally infected at pasture.
Topics: Animals; Antiprotozoal Agents; Cattle; Dairying; DNA, Protozoan; Female; Gene Dosage; Hematocrit; Incidence; Lactation; Longitudinal Studies; Naphthoquinones; Prevalence; Prospective Studies; Real-Time Polymerase Chain Reaction; Reproduction; Theileria; Theileriasis | 2019 |
Mutations in the TaPIN1 peptidyl prolyl isomerase gene in Theileria annulata parasites isolated in Sudan.
Topics: Animals; Antiprotozoal Agents; Cattle; Drug Resistance; Naphthoquinones; Peptidylprolyl Isomerase; Phenotype; Point Mutation; Sudan; Theileria annulata; Theileriasis | 2019 |
Topical buparvaquone nano-enabled hydrogels for cutaneous leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Hydrogels; Leishmaniasis, Cutaneous; Mice; Mice, Inbred BALB C; Naphthoquinones | 2020 |
Biogenic nanoporous silicon carrier improves the efficacy of buparvaquone against resistant visceral leishmaniasis.
Topics: Animals; Antiprotozoal Agents; Drug Carriers; Female; Hordeum; Injections, Intraperitoneal; Leishmania donovani; Leishmaniasis, Visceral; Macrophages; Mice, Inbred BALB C; Nanoparticles; Naphthoquinones; Silicon | 2021 |
Oral administration of buparvaquone nanostructured lipid carrier enables in vivo activity against Leishmania infantum.
Topics: Administration, Oral; Antiprotozoal Agents; Leishmania infantum; Lipids; Liposomes; Nanoparticles; Naphthoquinones | 2022 |
Metabolomic profiling of bovine leucocytes transformed by Theileria annulata under BW720c treatment.
Topics: Animals; Arginine; Carnitine; Cattle; Dimethyl Sulfoxide; Leucine; Naphthoquinones; Theileria; Theileria annulata; Theileriasis | 2022 |